OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · Real-Time Price · USD
6.74
-0.79 (-10.49%)
At close: Mar 6, 2026, 4:00 PM EST
6.67
-0.07 (-1.04%)
After-hours: Mar 6, 2026, 7:52 PM EST
Market Cap126.44M +4.5%
Revenue (ttm)109.43M +18.8%
Net Income5.13M
EPS0.27
Shares Out 18.76M
PE Ratio24.96
Forward PE6.97
Dividendn/a
Ex-Dividend Daten/a
Volume2,101,602
Open6.90
Previous Close7.53
Day's Range5.54 - 7.49
52-Week Range3.99 - 22.25
Beta1.24
AnalystsStrong Buy
Price Target16.67 (+147.33%)
Earnings DateMar 5, 2026

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and... [Read more]

Sector Healthcare
Founded 2006
Employees 129
Stock Exchange NASDAQ
Ticker Symbol OPRX
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for OPRX stock is "Strong Buy." The 12-month stock price target is $16.67, which is an increase of 147.33% from the latest price.

Price Target
$16.67
(147.33% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty

OptimizeRx Corp (NASDAQ: OPRX) shares are tumbling on Friday as the company faces increased market volatility and uncertainty surrounding Most Favored Nation (MFN) pricing.

1 day ago - Benzinga

OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript

OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript

1 day ago - Seeking Alpha

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 day ago - GlobeNewsWire

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 day ago - GlobeNewsWire

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

4 weeks ago - GlobeNewsWire

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage...

2 months ago - GlobeNewsWire

OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story

OptimizeRx's Q3 2025 results reinforce my long-term bullish thesis. OPRX demonstrates continued operational momentum, supporting confidence in sustained growth. Recent earnings solidify conviction in ...

2 months ago - Seeking Alpha

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

2 months ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

OptimizeRx Corporation ( OPRX) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Stephen Silvestro - President & CEO Edward Stelmakh - Chief Financial & Strategic Officer Andrew...

4 months ago - Seeking Alpha

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

-   Q3 revenue of $26.1 million, increased 22% year-over-year-   Q3 gross profit increased 30% year-over-year to $17.5 million-   Increases full year 2025 guidance to a revenue range between $105 mill...

4 months ago - GlobeNewsWire

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

4 months ago - GlobeNewsWire

4 Top AI-Powered Healthcare Stocks

Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthc...

Other symbols: BSXVEEVZEPP
5 months ago - Seeking Alpha

OptimizeRx: How The Stock Is Changing Pharma Marketing

OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue gro...

5 months ago - Seeking Alpha

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

6 months ago - GlobeNewsWire

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood ® Targeting Data with Lamar's Vast Nationwide OOH Network to  Strengthen OOH Media for Healthcare Marketing

6 months ago - GlobeNewsWire

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

7 months ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Andrew Jacob D'Silva - Senior Vice President of Corporate Finance Edward Stelmakh ...

7 months ago - Seeking Alpha

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

7 months ago - GlobeNewsWire

OptimizeRx: Stock Could Rise As Profitability Is Achieved

I expect OptimizeRx to turn profitable in 2025, driven by strong double-digit revenue growth and reduced operating expenses. The company's proprietary AI-powered omnichannel platform connects over 2 m...

8 months ago - Seeking Alpha

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

8 months ago - GlobeNewsWire

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

9 months ago - GlobeNewsWire

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

CANNES, France--(BUSINESS WIRE)-- #TV--Simulmedia announced a strategic partnership with OptimizeRx Corp. to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT).

9 months ago - Business Wire

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

10 months ago - GlobeNewsWire

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer ...

10 months ago - Seeking Alpha

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

10 months ago - GlobeNewsWire